Trader consensus prices "No" at 83.5% for a new COVID variant of concern before 2027, reflecting robust population immunity from vaccines and prior infections, coupled with declining national wastewater SARS-CoV-2 levels—now very low as of mid-March 2026—despite the recent spread of BA.3.2 ("Cicada"), a highly mutated Omicron sublineage detected in 25 U.S. states and 23 countries. Classified only as a WHO variant under monitoring since December 2025, not a VOC, it shows immune escape potential but no increased severity or hospitalizations, per CDC surveillance. Ongoing genomic tracking and updated LP.8.1 vaccines maintain stability, though a sudden surge in cases or virulence could shift odds.
Resumo experimental gerado por IA com dados do Polymarket · AtualizadoSim
$230,821 Vol.
$230,821 Vol.
31 dez 2026
Sim
$230,821 Vol.
$230,821 Vol.
31 dez 2026
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.Trader consensus prices "No" at 83.5% for a new COVID variant of concern before 2027, reflecting robust population immunity from vaccines and prior infections, coupled with declining national wastewater SARS-CoV-2 levels—now very low as of mid-March 2026—despite the recent spread of BA.3.2 ("Cicada"), a highly mutated Omicron sublineage detected in 25 U.S. states and 23 countries. Classified only as a WHO variant under monitoring since December 2025, not a VOC, it shows immune escape potential but no increased severity or hospitalizations, per CDC surveillance. Ongoing genomic tracking and updated LP.8.1 vaccines maintain stability, though a sudden surge in cases or virulence could shift odds.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Mercado Aberto: Dec 1, 2025, 4:49 PM ET
Volume
$230,821Data de Término
31 dez 2026Mercado Aberto
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.Trader consensus prices "No" at 83.5% for a new COVID variant of concern before 2027, reflecting robust population immunity from vaccines and prior infections, coupled with declining national wastewater SARS-CoV-2 levels—now very low as of mid-March 2026—despite the recent spread of BA.3.2 ("Cicada"), a highly mutated Omicron sublineage detected in 25 U.S. states and 23 countries. Classified only as a WHO variant under monitoring since December 2025, not a VOC, it shows immune escape potential but no increased severity or hospitalizations, per CDC surveillance. Ongoing genomic tracking and updated LP.8.1 vaccines maintain stability, though a sudden surge in cases or virulence could shift odds.
This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Volume
$230,821Data de Término
31 dez 2026Mercado Aberto
Dec 1, 2025, 4:49 PM ETResolver
0x65070BE91...Trader consensus prices "No" at 83.5% for a new COVID variant of concern before 2027, reflecting robust population immunity from vaccines and prior infections, coupled with declining national wastewater SARS-CoV-2 levels—now very low as of mid-March 2026—despite the recent spread of BA.3.2 ("Cicada"), a highly mutated Omicron sublineage detected in 25 U.S. states and 23 countries. Classified only as a WHO variant under monitoring since December 2025, not a VOC, it shows immune escape potential but no increased severity or hospitalizations, per CDC surveillance. Ongoing genomic tracking and updated LP.8.1 vaccines maintain stability, though a sudden surge in cases or virulence could shift odds.
Resumo experimental gerado por IA com dados do Polymarket · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions